Our findings suggest that administration of vasoprotective agents (for example, a S1PR2 antagonist) at the time of reperfusion could be a novel strategy to diminish cerebrovascular complications of reperfusion injury, ultimately resulting in less neurovascular injury and improved stroke outcomes52, 53, 54 (Fig. 9). Here, S1PR2 is linked to stroke disorder.